Injectable Nanoparticle‐Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist Antibodies-Reference-Cited by-同舟云学术

Injectable Nanoparticle‐Based Hydrogels Enable the Safe and Effective Deployment of Immunostimulatory CD40 Agonist Antibodies

Published:2022-08-17 Issue:28 Volume:9 Page:2103677
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Correa Santiago¹^ORCID,Meany Emily L.²,Gale Emily C.³^ORCID,Klich John H.²,Saouaf Olivia M.¹^ORCID,Mayer Aaron T.²,Xiao Zunyu²,Liong Celine S.²,Brown Ryanne A.⁴,Maikawa Caitlin L.²,Grosskopf Abigail K.⁵,Mann Joseph L.¹,Idoyaga Juliana⁶⁷⁸,Appel Eric A.¹⁷⁸⁹^ORCID

Affiliation:

1. Department of Materials Science and Engineering Stanford University Stanford CA 94305 USA

2. Department of Bioengineering Stanford University Stanford CA 94305 USA

3. Department of Biochemistry Stanford University School of Medicine Stanford CA 94305 USA

4. Department of Pathology Stanford University School of Medicine Stanford CA 94305 USA

5. Department of Chemical Engineering Stanford University Stanford CA 94305 USA

6. Department of Microbiology & Immunology Stanford University School of Medicine Stanford CA 94305 USA

7. Stanford ChEM‐H Institute Stanford University School of Medicine Stanford CA 94305 USA

8. Stanford Cancer Institute Stanford University School of Medicine Stanford CA 94305 USA

9. Department of Pediatrics – Endocrinology Stanford University School of Medicine Stanford CA 94305 USA

Funder

American Cancer Society

National Cancer Institute

National Institutes of Health

National Science Foundation

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202103677

Reference91 articles.

1. Raising the Bar: The Curative Potential of Human Cancer Immunotherapy

2. Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer

3. Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma

4. The future of immune checkpoint therapy

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Thermosensitive injectable fibrillar gels based on cellulose nanocrystals grafted with poly(N-isopropylacrylamide) as biocompatible brain implants;Carbohydrate Polymers;2024-12

2. The potential of biomimetic nanoparticles for macrophage repolarisation and phagocytosis in tumour immunotherapy;Chemical Engineering Journal;2024-10

3. Saponin nanoparticle adjuvants incorporating Toll-like receptor agonists drive distinct immune signatures and potent vaccine responses;Science Advances;2024-08-09

4. Reinforced polymer–nanoparticle hydrogels for subcutaneous and sustained delivery of trastuzumab;2024-07-31

5. Recent Advances in Hydrogel Technology in Delivering Mesenchymal Stem Cell for Osteoarthritis Therapy;Biomolecules;2024-07-17